The COVID-19 Immunity Task Force (CITF) is supporting over 100 studies to generate knowledge about immunity to SARS-CoV-2. The subjects addressed by these studies include the extent of SARS-CoV-2 infection in Canada, the nature of immunity, vaccine effectiveness and safety, and the need for booster shots among different communities and priority populations in Canada.

The CITF Databank was developed to further enhance the impact of our funded studies by allowing further research using the data collected for CITF-supported studies. The CITF harmonizes individual-level data deposited in the Databank to provide the research community, both in Canada and around the world, with ready access through our Data Portal to a wide variety of standardized COVID-19 data.